<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35727635</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>15</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e160989</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.160989</ELocationID><Abstract><AbstractText>Long COVID, a type of post-acute sequelae of SARS-CoV-2 (PASC), has been associated with sustained elevated levels of immune activation and inflammation. However, the mechanisms that drive this inflammation remain unknown. Inflammation during acute coronavirus disease 2019 could be exacerbated by microbial translocation (from the gut and/or lung) to blood. Whether microbial translocation contributes to inflammation during PASC is unknown. We did not observe a significant elevation in plasma markers of bacterial translocation during PASC. However, we observed higher levels of fungal translocation - measured as &#x3b2;-glucan, a fungal cell wall polysaccharide - in the plasma of individuals experiencing PASC compared with those without PASC or SARS-CoV-2-negative controls. The higher &#x3b2;-glucan correlated with higher inflammation and elevated levels of host metabolites involved in activating N-methyl-d-aspartate receptors (such as metabolites within the tryptophan catabolism pathway) with established neurotoxic properties. Mechanistically, &#x3b2;-glucan can directly induce inflammation by binding to myeloid cells (via Dectin-1) and activating Syk/NF-&#x3ba;B signaling. Using a Dectin-1/NF-&#x3ba;B reporter model, we found that plasma from individuals experiencing PASC induced higher NF-&#x3ba;B signaling compared with plasma from negative controls. This higher NF-&#x3ba;B signaling was abrogated by piceatannol (Syk inhibitor). These data suggest a potential targetable mechanism linking fungal translocation and inflammation during PASC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giron</LastName><ForeName>Leila B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jianyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenny</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zilberstein</LastName><ForeName>Netanel F</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koshy</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Kai Ying</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Nebraska-Lincoln, Lincoln, Nebraska, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Gregory E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Northwestern University, Evanston, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishehsari</LastName><ForeName>Faraz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balk</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moy</LastName><ForeName>James N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoh</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>Aaron R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hsin-Yao</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yee</LastName><ForeName>Brandon C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, Inc., Labcorp, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chenna</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, Inc., Labcorp, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winslow</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, Inc., Labcorp, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petropoulos</LastName><ForeName>Christos J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, Inc., Labcorp, South San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J Daniel</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasse</LastName><ForeName>Haimanot</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keshavarzian</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landay</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel-Mohsen</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Wistar Institute, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AA029859</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI158013</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK123733</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD023586</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 AA026801</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI141003</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA010815</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R50 CA221838</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI126521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI146268</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037181">Lectins, C-Type</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047071">beta-Glucans</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D000072377">Syk Kinase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JCI Insight. 2022 Sep 22;7(18):e164813. doi: 10.1172/jci.insight.164813</RefSource><PMID Version="1">36134654</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037181" MajorTopicYN="N">Lectins, C-Type</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072377" MajorTopicYN="N">Syk Kinase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047071" MajorTopicYN="Y">beta-Glucans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Tight junctions</Keyword><Keyword MajorTopicYN="N">Virology</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> AC, BCY, JWW, and CJP are employees of Monogram Biosciences, Inc., a division of Labcorp. SGD reports grants and/or personal fees from Gilead Sciences, Merck &amp; Co., ViiV Healthcare, AbbVie, Eli Lilly &amp; Co., BryoLogyx, and Enochian BioSciences. TJH reports grants from Merck and Co. and Bristol Myers Squibb.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35727635</ArticleId><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.160989</ArticleId><ArticleId IdType="pii">160989</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu Y, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656&#x2013;657. doi: 10.1016/S1473-3099(20)30232-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30232-2</ArticleId><ArticleId IdType="pmc">PMC7158902</ArticleId><ArticleId IdType="pubmed">32199493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Long covid could be four different syndromes, review suggests. BMJ. 2020;371:m3981.</Citation><ArticleIdList><ArticleId IdType="pubmed">33055076</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. 2020;21(1):163. doi: 10.1186/s12931-020-01429-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cienfuegos JA, et al. COVID-19. Immunothrombosis and the gastrointestinal tract. Rev Esp Enferm Dig. 2020;112(7):583&#x2013;584. doi: 10.17235/reed.2020.7292/2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.17235/reed.2020.7292/2020</ArticleId><ArticleId IdType="pubmed">32579012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77(8):1018&#x2013;1027. doi: 10.1001/jamaneurol.2020.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>[No authors listed. ] Meeting the challenge of long COVID. Nat Med. 2020;26(12):1803. doi: 10.1038/s41591-020-01177-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01177-6</ArticleId><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study [preprint]. Posted on medRxiv December 16, 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.15.20248096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, et al. Characteristics of adult outpatients and inpatients with COVID-19 &#x2014; 11 academic medical centers, United States, March-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(26):841&#x2013;846. doi: 10.15585/mmwr.mm6926e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6926e3</ArticleId><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortinovis M, et al. Long-term follow-up of recovered patients with COVID-19. Lancet. 2021;397(10270):173&#x2013;175. doi: 10.1016/S0140-6736(21)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00039-8</ArticleId><ArticleId IdType="pmc">PMC7833833</ArticleId><ArticleId IdType="pubmed">33428868</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Darley D, et al. Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort. ERJ Open Res. 2021;7(4):00384&#x2013;2021. doi: 10.1183/23120541.00384-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00384-2021</ArticleId><ArticleId IdType="pmc">PMC8504133</ArticleId><ArticleId IdType="pubmed">34725634</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis. 2022;9(2):ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis. 2021;9(2):ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, et al. Role of antibodies, inflammatory markers, and echocardiographic findings in post-acute cardiopulmonary symptoms after SARS-CoV-2 infection. JCI Insight. 2022;7(10):157053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220849</ArticleId><ArticleId IdType="pubmed">35389890</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC) [preprint]. Posted on medRxiv November 4, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.02.21265778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43(4):268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas A, et al. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol. 2018;20(12):e12966. doi: 10.1111/cmi.12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12966</ArticleId><ArticleId IdType="pubmed">30329198</ArticleId></ArticleIdList></Reference><Reference><Citation>Frati F, et al. The role of the microbiome in asthma: the gut-lung axis. Int J Mol Sci. 2018;20(1):123. doi: 10.3390/ijms20010123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010123</ArticleId><ArticleId IdType="pmc">PMC6337651</ArticleId><ArticleId IdType="pubmed">30598019</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Hanidziar D. More of the gut in the lung: how two microbiomes meet in ARDS. Yale J Biol Med. 2018;91(2):143&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020735</ArticleId><ArticleId IdType="pubmed">29955219</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson RP, et al. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol. 2016;1(10):16113. doi: 10.1038/nmicrobiol.2016.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.113</ArticleId><ArticleId IdType="pmc">PMC5076472</ArticleId><ArticleId IdType="pubmed">27670109</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667&#x2013;678. doi: 10.1016/S2468-1253(20)30126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30126-6</ArticleId><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766&#x2013;773. doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruewer M, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171(11):6164&#x2013;6172. doi: 10.4049/jimmunol.171.11.6164.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.11.6164</ArticleId><ArticleId IdType="pubmed">14634132</ArticleId></ArticleIdList></Reference><Reference><Citation>Capaldo CT, et al. Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol Cell. 2014;25(18):2710&#x2013;2719. doi: 10.1091/mbc.e14-02-0773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e14-02-0773</ArticleId><ArticleId IdType="pmc">PMC4161507</ArticleId><ArticleId IdType="pubmed">25031428</ArticleId></ArticleIdList></Reference><Reference><Citation>Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788(4):864&#x2013;871. doi: 10.1016/j.bbamem.2008.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2008.08.027</ArticleId><ArticleId IdType="pmc">PMC2699410</ArticleId><ArticleId IdType="pubmed">18952050</ArticleId></ArticleIdList></Reference><Reference><Citation>Enaud R, et al. The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol. 2020;10:9. doi: 10.3389/fcimb.2020.00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00009</ArticleId><ArticleId IdType="pmc">PMC7042389</ArticleId><ArticleId IdType="pubmed">32140452</ArticleId></ArticleIdList></Reference><Reference><Citation>Loverdos K, et al. Lung microbiome in asthma: current perspectives. J Clin Med. 2019;8(11): 1967. doi: 10.3390/jcm8111967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111967</ArticleId><ArticleId IdType="pmc">PMC6912699</ArticleId><ArticleId IdType="pubmed">31739446</ArticleId></ArticleIdList></Reference><Reference><Citation>Madan JC, et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. mBio. 2012;3(4):e00251&#x2013;12. doi: 10.1128/mBio.00251-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00251-12</ArticleId><ArticleId IdType="pmc">PMC3428694</ArticleId><ArticleId IdType="pubmed">22911969</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol. 2007;127(11):2525&#x2013;2532. doi: 10.1038/sj.jid.5700865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.jid.5700865</ArticleId><ArticleId IdType="pubmed">17934504</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799&#x2013;809. doi: 10.1038/nri2653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2653</ArticleId><ArticleId IdType="pubmed">19855405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley JM, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749&#x2013;759. doi: 10.1084/jem.20040874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20040874</ArticleId><ArticleId IdType="pmc">PMC2211962</ArticleId><ArticleId IdType="pubmed">15365096</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31. doi: 10.1186/s40168-015-0094-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-015-0094-5</ArticleId><ArticleId IdType="pmc">PMC4520061</ArticleId><ArticleId IdType="pubmed">26229597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hager CL, Ghannoum MA. The mycobiome in HIV. Curr Opin HIV AIDS. 2018;13(1):69&#x2013;72. doi: 10.1097/COH.0000000000000432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000432</ArticleId><ArticleId IdType="pmc">PMC5805152</ArticleId><ArticleId IdType="pubmed">29028668</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash AK, et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 2017;5(1):153. doi: 10.1186/s40168-017-0373-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0373-4</ArticleId><ArticleId IdType="pmc">PMC5702186</ArticleId><ArticleId IdType="pubmed">29178920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol (Camb) 2015;7(11):1339&#x2013;1377. doi: 10.1039/c5ib00158g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5ib00158g</ArticleId><ArticleId IdType="pubmed">26345428</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM. Endotoxins and other sepsis triggers. Contrib Nephrol. 2010;167:14&#x2013;24. doi: 10.1159/000315915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315915</ArticleId><ArticleId IdType="pubmed">20519895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue C, et al. Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation. Inflammation. 2012;35(6):1880&#x2013;1888. doi: 10.1007/s10753-012-9510-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-012-9510-1</ArticleId><ArticleId IdType="pubmed">22821406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoenigl M, et al. (1&#x2192;3)-&#x3b2;-d-Glucan: a biomarker for microbial translocation in individuals with acute or early HIV infection? Front Immunol. 2016;7:404. doi: 10.3389/fimmu.2016.00404.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00404</ArticleId><ArticleId IdType="pmc">PMC5046804</ArticleId><ArticleId IdType="pubmed">27752257</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner LD, et al. Fungal translocation is associated with immune activation and systemic inflammation in treated HIV. AIDS Res Hum Retroviruses. 2019;35(5):461&#x2013;472. doi: 10.1089/aid.2018.0252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2018.0252</ArticleId><ArticleId IdType="pmc">PMC6516070</ArticleId><ArticleId IdType="pubmed">30784316</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnard S, et al. Gut leakage of fungal-related products: turning up the heat for HIV infection. Front Immunol. 2021;12:656414. doi: 10.3389/fimmu.2021.656414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656414</ArticleId><ArticleId IdType="pmc">PMC8071945</ArticleId><ArticleId IdType="pubmed">33912183</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151&#x2013;175. doi: 10.1152/physrev.00003.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00003.2008</ArticleId><ArticleId IdType="pubmed">21248165</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi A, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009;106(39):16799&#x2013;16804. doi: 10.1073/pnas.0906773106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906773106</ArticleId><ArticleId IdType="pmc">PMC2744629</ArticleId><ArticleId IdType="pubmed">19805376</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, et al. Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front Immunol. 2021;12:686240. doi: 10.3389/fimmu.2021.686240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686240</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71(10):2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel H, et al. Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement. J Intern Med. 2021;289(4):523&#x2013;531. doi: 10.1111/joim.13178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13178</ArticleId><ArticleId IdType="pmc">PMC7536991</ArticleId><ArticleId IdType="pubmed">32976665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L, et al. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features. Commun Biol. 2021;4(1):480. doi: 10.1038/s42003-021-02036-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02036-x</ArticleId><ArticleId IdType="pmc">PMC8044104</ArticleId><ArticleId IdType="pubmed">33850296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70(7):1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70(2):276&#x2013;284. doi: 10.1136/gutjnl-2020-322294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322294</ArticleId><ArticleId IdType="pmc">PMC7385744</ArticleId><ArticleId IdType="pubmed">32690600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;1310. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>El Asmar R, et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology. 2002;123(5):1607&#x2013;1615. doi: 10.1053/gast.2002.36578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/gast.2002.36578</ArticleId><ArticleId IdType="pubmed">12404235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood Heickman LK, et al. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev. 2020;36(5):e3309. doi: 10.1002/dmrr.3309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3309</ArticleId><ArticleId IdType="pmc">PMC7340576</ArticleId><ArticleId IdType="pubmed">32162764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitsios GD, et al. Plasma 1,3-&#x3b2;-d-glucan levels predict adverse clinical outcomes in critical illness. JCI Insight. 2021;6(14):141277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410081</ArticleId><ArticleId IdType="pubmed">34128840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirajlal-Fargo S, et al. Changes in the fungal marker &#x3b2;-D-glucan after antiretroviral therapy and association with adiposity. Open Forum Infect Dis. 2019;6(11):ofz434. doi: 10.1093/ofid/ofz434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz434</ArticleId><ArticleId IdType="pmc">PMC6847395</ArticleId><ArticleId IdType="pubmed">31737737</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar Rodriguez M, et al. Obesity changes the human gut mycobiome. Sci Rep. 2015;5:14600. doi: 10.1038/srep14600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14600</ArticleId><ArticleId IdType="pmc">PMC4600977</ArticleId><ArticleId IdType="pubmed">26455903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MF, et al. &#x3b2;-glucan-activated human B lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis. J Immunol. 2015;195(11):5318&#x2013;5326. doi: 10.4049/jimmunol.1500559.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500559</ArticleId><ArticleId IdType="pmc">PMC4655155</ArticleId><ArticleId IdType="pubmed">26519534</ArticleId></ArticleIdList></Reference><Reference><Citation>Elder MJ, et al. &#x3b2;-glucan size controls dectin-1-mediated immune responses in human dendritic cells by regulating IL-1&#x3b2; production. Front Immunol. 2017;8:791. doi: 10.3389/fimmu.2017.00791.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00791</ArticleId><ArticleId IdType="pmc">PMC5500631</ArticleId><ArticleId IdType="pubmed">28736555</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JU, et al. Differential dependencies of monocytes and neutrophils on dectin-1, dectin-2 and complement for the recognition of fungal particles in inflammation. PLoS One. 2012;7(9):e45781. doi: 10.1371/journal.pone.0045781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045781</ArticleId><ArticleId IdType="pmc">PMC3458947</ArticleId><ArticleId IdType="pubmed">23049859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramendra R, et al. Glutathione metabolism is a regulator of the acute inflammatory response of monocytes to (1&#x2192;3)-&#x3b2;-D-glucan. Front Immunol. 2021;12:694152. doi: 10.3389/fimmu.2021.694152.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.694152</ArticleId><ArticleId IdType="pmc">PMC8631827</ArticleId><ArticleId IdType="pubmed">34858388</ArticleId></ArticleIdList></Reference><Reference><Citation>Davaatseren M, et al. Poly-&#x3b3;-glutamic acid attenuates angiogenesis and inflammation in experimental colitis. Mediators Inflamm. 2013;2013:982383. doi: 10.1155/2013/982383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/982383</ArticleId><ArticleId IdType="pmc">PMC3671540</ArticleId><ArticleId IdType="pubmed">23766568</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd A, et al. Serum tryptophan-derived quinolinate and indole-3-acetate are associated with carotid intima-media thickness and its evolution in HIV-infected treated adults. Open Forum Infect Dis. 2019;6(12):ofz516. doi: 10.1093/ofid/ofz516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz516</ArticleId><ArticleId IdType="pmc">PMC6929253</ArticleId><ArticleId IdType="pubmed">31890722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kardashian A, et al. High kynurenine:tryptophan ratio is associated with liver fibrosis in HIV-monoinfected and HIV/hepatitis C virus-coinfected women. Open Forum Infect Dis. 2019;6(7):ofz281. doi: 10.1093/ofid/ofz281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz281</ArticleId><ArticleId IdType="pmc">PMC6612851</ArticleId><ArticleId IdType="pubmed">31304190</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez P, et al. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr. 2014;65(4):456&#x2013;462. doi: 10.1097/QAI.0000000000000062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000000062</ArticleId><ArticleId IdType="pmc">PMC3943704</ArticleId><ArticleId IdType="pubmed">24220289</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon JY, et al. Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection. EBioMedicine. 2018;37:392&#x2013;400. doi: 10.1016/j.ebiom.2018.10.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.10.037</ArticleId><ArticleId IdType="pmc">PMC6286648</ArticleId><ArticleId IdType="pubmed">30366816</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Q, et al. Plasma tryptophan-kynurenine metabolites are altered in human immunodeficiency virus infection and associated with progression of carotid artery atherosclerosis. Clin Infect Dis. 2018;67(2):235&#x2013;242. doi: 10.1093/cid/ciy053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy053</ArticleId><ArticleId IdType="pmc">PMC6031054</ArticleId><ArticleId IdType="pubmed">29415228</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, et al. Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci Signal. 2021;14(690):eabf8483. doi: 10.1126/scisignal.abf8483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abf8483</ArticleId><ArticleId IdType="pmc">PMC8432948</ArticleId><ArticleId IdType="pubmed">34230210</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewes JL, et al. Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. J Neurovirol. 2015;21(4):449&#x2013;463. doi: 10.1007/s13365-015-0334-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-015-0334-2</ArticleId><ArticleId IdType="pmc">PMC4512924</ArticleId><ArticleId IdType="pubmed">25776527</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillemin GJ. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012;279(8):1356&#x2013;1365. doi: 10.1111/j.1742-4658.2012.08485.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2012.08485.x</ArticleId><ArticleId IdType="pubmed">22248144</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz R, et al. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13(7):465&#x2013;477. doi: 10.1038/nrn3257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3257</ArticleId><ArticleId IdType="pmc">PMC3681811</ArticleId><ArticleId IdType="pubmed">22678511</ArticleId></ArticleIdList></Reference><Reference><Citation>Plate J, et al. S-sulfocysteine induces seizure-like behaviors in zebrafish. Front Pharmacol. 2019;10:122. doi: 10.3389/fphar.2019.00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00122</ArticleId><ArticleId IdType="pmc">PMC6454129</ArticleId><ArticleId IdType="pubmed">31001109</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehraj V, et al. Circulating (1&#x2192;3)-&#x3b2;-D-glucan is associated with immune activation during human immunodeficiency virus infection. Clin Infect Dis. 2020;70(2):232&#x2013;241. doi: 10.1093/cid/ciz212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz212</ArticleId><ArticleId IdType="pmc">PMC6938980</ArticleId><ArticleId IdType="pubmed">30877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Isnard S, et al. Circulating &#x3b2;-d-glucan as a marker of subclinical coronary plaque in antiretroviral therapy-treated people with human immunodeficiency virus. Open Forum Infect Dis. 2021;8(6):ofab109. doi: 10.1093/ofid/ofab109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab109</ArticleId><ArticleId IdType="pmc">PMC8232386</ArticleId><ArticleId IdType="pubmed">34189152</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A, et al. Serum (1&#x2192;3)-&#x3b2;-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function. J Acquir Immune Defic Syndr. 2012;61(4):462&#x2013;468. doi: 10.1097/QAI.0b013e318271799b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0b013e318271799b</ArticleId><ArticleId IdType="pmc">PMC3494803</ArticleId><ArticleId IdType="pubmed">22972021</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajik N, et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun. 2020;11(1):1995. doi: 10.1038/s41467-020-15831-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15831-7</ArticleId><ArticleId IdType="pmc">PMC7181728</ArticleId><ArticleId IdType="pubmed">32332732</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts T, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A. 2005;102(8):2916&#x2013;2921. doi: 10.1073/pnas.0500178102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0500178102</ArticleId><ArticleId IdType="pmc">PMC549484</ArticleId><ArticleId IdType="pubmed">15710870</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler DA, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology. 2015;148(7):1311&#x2013;1319. doi: 10.1053/j.gastro.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2015.02.008</ArticleId><ArticleId IdType="pmc">PMC4446229</ArticleId><ArticleId IdType="pubmed">25683116</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker LM, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021;131(14):149633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye XC, et al. Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice. J Neuroinflammation. 2020;17(1):17. doi: 10.1186/s12974-019-1693-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1693-z</ArticleId><ArticleId IdType="pmc">PMC6954534</ArticleId><ArticleId IdType="pubmed">31926564</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, et al. Inhibition of dectin-1 signaling ameliorates colitis by inducing lactobacillus-mediated regulatory T cell expansion in the intestine. Cell Host Microbe. 2015;18(2):183&#x2013;197. doi: 10.1016/j.chom.2015.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.07.003</ArticleId><ArticleId IdType="pubmed">26269954</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B, et al. Microbial genetic composition tunes host longevity. Cell. 2017;169(7):1249&#x2013;1262. doi: 10.1016/j.cell.2017.05.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.036</ArticleId><ArticleId IdType="pmc">PMC5635830</ArticleId><ArticleId IdType="pubmed">28622510</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med. 2014;30(1):79&#x2013;93. doi: 10.1016/j.cger.2013.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2013.10.008</ArticleId><ArticleId IdType="pubmed">24267604</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc. 2015;63(4):776&#x2013;781. doi: 10.1111/jgs.13310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.13310</ArticleId><ArticleId IdType="pmc">PMC4406803</ArticleId><ArticleId IdType="pubmed">25851728</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RI, et al. Distinct shifts in microbiota composition during Drosophila aging impair intestinal function and drive mortality. Cell Rep. 2015;12(10):1656&#x2013;1667. doi: 10.1016/j.celrep.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4565751</ArticleId><ArticleId IdType="pubmed">26321641</ArticleId></ArticleIdList></Reference><Reference><Citation>Langille MG, et al. Microbial shifts in the aging mouse gut. Microbiome. 2014;2(1):50. doi: 10.1186/s40168-014-0050-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-014-0050-9</ArticleId><ArticleId IdType="pmc">PMC4269096</ArticleId><ArticleId IdType="pubmed">25520805</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole PW, Jeffery IB. Gut microbiota and aging. Science. 2015;350(6265):1214&#x2013;1215. doi: 10.1126/science.aac8469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac8469</ArticleId><ArticleId IdType="pubmed">26785481</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P, et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife. 2017;6:e27014. doi: 10.7554/eLife.27014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.27014</ArticleId><ArticleId IdType="pmc">PMC5566455</ArticleId><ArticleId IdType="pubmed">28826469</ArticleId></ArticleIdList></Reference><Reference><Citation>Thevaranjan N, et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe. 2017;21(4):455&#x2013;466. doi: 10.1016/j.chom.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.03.002</ArticleId><ArticleId IdType="pmc">PMC5392495</ArticleId><ArticleId IdType="pubmed">28407483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KA, et al. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice. BMC Microbiol. 2016;16:9. doi: 10.1186/s12866-016-0625-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-016-0625-7</ArticleId><ArticleId IdType="pmc">PMC4715324</ArticleId><ArticleId IdType="pubmed">26772806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh AK, et al. Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging. Aging (Albany NY) 2017;9(9):1971&#x2013;1982. doi: 10.18632/aging.101288.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101288</ArticleId><ArticleId IdType="pmc">PMC5636669</ArticleId><ArticleId IdType="pubmed">28898202</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen F, et al. Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice. Front Immunol. 2017;8:1385. doi: 10.3389/fimmu.2017.01385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01385</ArticleId><ArticleId IdType="pmc">PMC5674680</ArticleId><ArticleId IdType="pubmed">29163474</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulbright LE, et al. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017;13(9):e1006480. doi: 10.1371/journal.ppat.1006480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006480</ArticleId><ArticleId IdType="pmc">PMC5608396</ArticleId><ArticleId IdType="pubmed">28934351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni J, et al. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol. 2017;14(10):573&#x2013;584. doi: 10.1038/nrgastro.2017.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.88</ArticleId><ArticleId IdType="pmc">PMC5880536</ArticleId><ArticleId IdType="pubmed">28743984</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun. 2013;4:2163. doi: 10.1038/ncomms3163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3163</ArticleId><ArticleId IdType="pmc">PMC3717500</ArticleId><ArticleId IdType="pubmed">23860099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli M, et al. Prevalence of small intestinal bacterial overgrowth in Parkinson&#x2019;s disease. Mov Disord. 2011;26(5):889&#x2013;892. doi: 10.1002/mds.23566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23566</ArticleId><ArticleId IdType="pubmed">21520278</ArticleId></ArticleIdList></Reference><Reference><Citation>Narozanska E, et al. Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection. Clin Neuropharmacol. 2014;37(4):96&#x2013;99. doi: 10.1097/WNF.0000000000000037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNF.0000000000000037</ArticleId><ArticleId IdType="pubmed">24992088</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu XL, et al. Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson&#x2019;s disease. J Neural Transm (Vienna) 2016;123(12):1381&#x2013;1386. doi: 10.1007/s00702-016-1612-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-016-1612-8</ArticleId><ArticleId IdType="pubmed">27589873</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors. Nat Rev Neurol. 2015;11(11):625&#x2013;636. doi: 10.1038/nrneurol.2015.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.197</ArticleId><ArticleId IdType="pubmed">26503923</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe L, et al. Prebiotic and probiotic regulation of bone health: role of the intestine and its microbiome. Curr Osteoporos Rep. 2015;13(6):363&#x2013;371. doi: 10.1007/s11914-015-0292-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11914-015-0292-x</ArticleId><ArticleId IdType="pmc">PMC4623939</ArticleId><ArticleId IdType="pubmed">26419466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjogren K, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012;27(6):1357&#x2013;1367. doi: 10.1002/jbmr.1588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.1588</ArticleId><ArticleId IdType="pmc">PMC3415623</ArticleId><ArticleId IdType="pubmed">22407806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridaura VK, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214. doi: 10.1126/science.1241214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1241214</ArticleId><ArticleId IdType="pmc">PMC3829625</ArticleId><ArticleId IdType="pubmed">24009397</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley RJ, et al. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21(3):369&#x2013;378. doi: 10.1016/j.cmet.2015.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.01.001</ArticleId><ArticleId IdType="pmc">PMC4351155</ArticleId><ArticleId IdType="pubmed">25662404</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol. 2012;30:149&#x2013;173. doi: 10.1146/annurev-immunol-020711-075001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-075001</ArticleId><ArticleId IdType="pmc">PMC3513328</ArticleId><ArticleId IdType="pubmed">22224779</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley JM, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365&#x2013;1371. doi: 10.1038/nm1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1511</ArticleId><ArticleId IdType="pubmed">17115046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuller LH, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203. doi: 10.1371/journal.pmed.0050203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050203</ArticleId><ArticleId IdType="pmc">PMC2570418</ArticleId><ArticleId IdType="pubmed">18942885</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodger AJ, et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis. 2009;200(6):973&#x2013;983. doi: 10.1086/605447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605447</ArticleId><ArticleId IdType="pmc">PMC2892757</ArticleId><ArticleId IdType="pubmed">19678756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler NG, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203(6):780&#x2013;790. doi: 10.1093/infdis/jiq118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiq118</ArticleId><ArticleId IdType="pmc">PMC3071127</ArticleId><ArticleId IdType="pubmed">21252259</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48&#x2013;62. doi: 10.1056/NEJMra041811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra041811</ArticleId><ArticleId IdType="pubmed">15635112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt PW, et al. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS. 2011;25(17):2123&#x2013;2131. doi: 10.1097/QAD.0b013e32834c4ac1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32834c4ac1</ArticleId><ArticleId IdType="pmc">PMC3480326</ArticleId><ArticleId IdType="pubmed">21881481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons JL, et al. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011;57(5):371&#x2013;379. doi: 10.1097/QAI.0b013e3182237e54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0b013e3182237e54</ArticleId><ArticleId IdType="pmc">PMC3159710</ArticleId><ArticleId IdType="pubmed">21646912</ArticleId></ArticleIdList></Reference><Reference><Citation>Tincati C, et al. CD8+ hyperactivation and senescence correlate with early carotid intima-media thickness in HIV+ patients with no cardiovascular disease. J Acquir Immune Defic Syndr. 2009;51(5):642&#x2013;644. doi: 10.1097/QAI.0b013e3181add695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0b013e3181add695</ArticleId><ArticleId IdType="pubmed">19628982</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200(6):761&#x2013;770. doi: 10.1084/jem.20041196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041196</ArticleId><ArticleId IdType="pmc">PMC2211967</ArticleId><ArticleId IdType="pubmed">15365095</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23&#x2013;30. doi: 10.1038/mi.2007.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2007.1</ArticleId><ArticleId IdType="pmc">PMC2777614</ArticleId><ArticleId IdType="pubmed">19079157</ArticleId></ArticleIdList></Reference><Reference><Citation>Macal M, et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 2008;1(6):475&#x2013;488. doi: 10.1038/mi.2008.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2008.35</ArticleId><ArticleId IdType="pubmed">19079215</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection [preprint]. Posted on February 26, 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.10.22270471</ArticleId><ArticleId IdType="pmc">PMC9444925</ArticleId><ArticleId IdType="pubmed">35866847</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann A, et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat Commun. 2020;11(1):3730. doi: 10.1038/s41467-020-17489-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17489-7</ArticleId><ArticleId IdType="pmc">PMC7381622</ArticleId><ArticleId IdType="pubmed">32709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao K, et al. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr. 2020;11(3):709&#x2013;723. doi: 10.1093/advances/nmz127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmz127</ArticleId><ArticleId IdType="pmc">PMC7231603</ArticleId><ArticleId IdType="pubmed">31825083</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinken A, et al. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis. NPJ Syst Biol Appl. 2021;7(1):19. doi: 10.1038/s41540-021-00178-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41540-021-00178-6</ArticleId><ArticleId IdType="pmc">PMC8102608</ArticleId><ArticleId IdType="pubmed">33958598</ArticleId></ArticleIdList></Reference><Reference><Citation>Dingledine R, et al. The glutamate receptor ion channels. Pharmacol Rev. 1999;51(1):7&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10049997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci. 2002;(suppl 5):1039&#x2013;1042. doi: 10.1038/nn936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn936</ArticleId><ArticleId IdType="pubmed">12403981</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch HJ, et al. NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer&#x2019;s and vascular dementia. Curr Pharm Des. 2004;10(3):253&#x2013;259. doi: 10.2174/1381612043386392.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612043386392</ArticleId><ArticleId IdType="pubmed">14754385</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov. 2006;5(2):160&#x2013;170. doi: 10.1038/nrd1958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1958</ArticleId><ArticleId IdType="pubmed">16424917</ArticleId></ArticleIdList></Reference><Reference><Citation>Steullet P, et al. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience. 2006;137(3):807&#x2013;819. doi: 10.1016/j.neuroscience.2005.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2005.10.014</ArticleId><ArticleId IdType="pubmed">16330153</ArticleId></ArticleIdList></Reference><Reference><Citation>Mount C, Downton C. Alzheimer disease: progress or profit? Nat Med. 2006;12(7):780&#x2013;784. doi: 10.1038/nm0706-780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0706-780</ArticleId><ArticleId IdType="pubmed">16829947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoli F, et al. Repurposed drugs as adjunctive treatments for mania and bipolar depression: a meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials. J Psychiatr Res. 2021;143:230&#x2013;238. doi: 10.1016/j.jpsychires.2021.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.018</ArticleId><ArticleId IdType="pubmed">34509090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong MP, Erickson CA. Investigational drugs in early-stage clinical trials for autism spectrum disorder. Expert Opin Investig Drugs. 2019;28(8):709&#x2013;718. doi: 10.1080/13543784.2019.1649656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2019.1649656</ArticleId><ArticleId IdType="pubmed">31352835</ArticleId></ArticleIdList></Reference><Reference><Citation>Parr J. Autism. BMJ Clin Evid. 2010;2010:0322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2907623</ArticleId><ArticleId IdType="pubmed">21729335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang J, et al. Daily variations of gut microbial translocation markers in ART-treated HIV-infected people. AIDS Res Ther. 2020;17(1):15. doi: 10.1186/s12981-020-00273-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12981-020-00273-4</ArticleId><ArticleId IdType="pmc">PMC7216536</ArticleId><ArticleId IdType="pubmed">32398104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed DS, et al. Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity. Front Immunol. 2022;13:820350. doi: 10.3389/fimmu.2022.820350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.820350</ArticleId><ArticleId IdType="pmc">PMC8888851</ArticleId><ArticleId IdType="pubmed">35251002</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36(6):109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, et al. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258&#x2013;266. doi: 10.1097/00006842-200203000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-200203000-00008</ArticleId><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337&#x2013;343. doi: 10.3109/07853890109002087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002087</ArticleId><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, et al. The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells. Sci Signal. 2020;13(642):eaaz8240. doi: 10.1126/scisignal.aaz8240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaz8240</ArticleId><ArticleId IdType="pmc">PMC7484983</ArticleId><ArticleId IdType="pubmed">32723812</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, et al. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021;12(1):3922. doi: 10.1038/s41467-021-24077-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24077-w</ArticleId><ArticleId IdType="pmc">PMC8241829</ArticleId><ArticleId IdType="pubmed">34188039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>